公司資料
Aura Biosciences 股價、新聞與催化劑
- 股票代碼:
- AURA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
6.09 USD (+0.83%)
收盤價
最後更新: 2026年10月2日
713M USD
市值
股價為何變動
截至 2026年10月2日，AURA 上漲 0.83%，收於 $6.09。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Aura Biosciences is a biotechnology company focused on precision oncology and tumor-targeting therapies. Its story is built around using targeted biologics to deliver treatment specifically to tumors.
所在地與產業分類
Aura Biosciences is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商業模式特徵
The company depends on clinical data, translational validation, and the ability to develop a narrow but differentiated cancer pipeline. Investors usually watch efficacy, safety, and strategic milestones.
生技產業定位
Aura occupies a precision-oncology niche within biotech. It is catalyst-sensitive because the market needs evidence that the targeted approach can create real clinical value.
未來催化劑
- Aura Biosciences’s catalysts are bel-sar and the ocular-oncology platform, where the next clinical update can materially change the story. The market cares about whether the platform keeps differentiating itself.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。